World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 19 February 2015
Main ID:  NCT00301301
Date of registration: 09/03/2006
Prospective Registration: No
Primary sponsor: Royal Marsden NHS Foundation Trust
Public title: A Retrospective Review of Gemcitabine, Methylprednisolone Cisplatin (GEM-P) With or Without Rituximab in Patients With Relapsed/Refractory Diffuse Large B Cell Lymphoma (DLBCL)
Scientific title:
Date of first enrolment: June 2002
Target sample size: 39
Recruitment status: Completed
URL:  http://clinicaltrials.gov/show/NCT00301301
Study type:  Observational
Study design:  Time Perspective: Retrospective  
Phase:  N/A
Countries of recruitment
United Kingdom
Contacts
Name:     David Cunningham, FRCP
Address: 
Telephone:
Email:
Affiliation:  Royal Marsden NHS Foundation Trust
Key inclusion & exclusion criteria

Inclusion Criteria:

- a) Age over 18 b) Histological diagnosis of diffuse large B cell lymphoma c) Patients
who have received Gemcitabine-cisplatin, methylprednisolone (GEM-P) as per standard unit
guidelines with or without Rituximab for relapsed/refractory DLBCL.

d) Informed written consent

Exclusion Criteria:

- a) Medical or psychiatric conditions that compromise the patient's ability to give
informed consent b) HIV positive or AIDS related lymphoma



Age minimum: 18 Years
Age maximum: N/A
Gender: Both
Health Condition(s) or Problem(s) studied
Non-Hodgkins Lymphoma
Intervention(s)
Drug: Rituximab
Drug: Gemcitabine
Drug: Cisplatinum
Primary Outcome(s)
Secondary Outcome(s)
Secondary ID(s)
2656
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history